Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TORICO, Last Fiscal Year Net Income Loss Widened in Downward Revision
7138 TORICO Co., Ltd. 【J-GAAP】
Guidance Update ReportTORICO Co., Ltd. <7138> [TSE Growth] announced a performance revision after the market closed on April 25th (15:30). The consolidated net income/loss for the fiscal year ending March 2025 has been revised downward from an expected loss of 289 million yen to a loss of 436 million yen (compared to a loss of 272 million yen in the previous period), indicating an expansion in the loss margin.
Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated net income/loss has been revised downward from an expected loss of 150 million yen to a loss of 297 million yen (compared to a loss of 127 million yen in the same period of the previous year), indicating an expansion in the loss margin.
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 1,814 | -115 | -117 | -150 | -95.2 | 0 | Feb 13, 2025 | J-GAAP |
Oct - Mar, 2024 New | 1,778 | -123 | -120 | -297 | -196.6 | 0 | Apr 25, 2025 | J-GAAP |
Revision Rate | -2.0% | -7.0% | -2.6% | -98.0% | -106.5% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 3,713 | -244 | -252 | -289 | -183.5 | 0 | Feb 13, 2025 | J-GAAP |
Mar, 2025 New | 3,677 | -252 | -255 | -436 | -288.7 | 0 | Apr 25, 2025 | J-GAAP |
Revision Rate | -1.0% | -3.3% | -1.2% | -50.9% | -57.3% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 2,014 | -126 | -126 | -127 | -104.4 | 0 | May 13, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 1,778 | -123 | -120 | -297 | -196.6 | 0 | Apr 25, 2025 | J-GAAP |
YoY | -11.7% | +2.4% | +4.8% | -133.9% | -88.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 5,004 | 130 | 128 | 74 | 60.4 | 0 | May 12, 2023 | J-GAAP |
Mar, 2024 | 3,897 | -222 | -224 | -272 | -223.6 | 0 | May 13, 2024 | J-GAAP |
Mar, 2025 Guidance | 3,677 | -252 | -255 | -436 | -288.7 | 0 | Apr 25, 2025 | J-GAAP |
YoY | -5.6% | -13.5% | -13.8% | -60.3% | -29.1% |
Related Articles
AXYZ, The Current Fiscal Year Ordinary Profit Revised Upward by 36%
TOHO LAMAC, Jan-Mar (1Q) Ordinary Profit Turns to Loss
Kawagishi Bridge Works, First Half Ordinary Profit Revised Upward to an Unexpected 8% Increase
ADVANTEST, 11% Increase in Net Income, Update Record High for Second Consecutive Term
Astellas Pharma, Last Fiscal Year's Net Income Unexpectedly Increases, 2.6 times Increase in Net Income for The Current Fiscal Year, Dividend Raised by 4 yen
ANRITSU, 19% Increase in Net Income for The Current Fiscal Year
ZENITAKA, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 2% Increase, Dividend Revised Upward by 20 yen
TORII PHARMA, Jan-Mar (1Q) Ordinary Profit Increases by 59%
SEMITEC, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 5% Increase
TOWNNEWS-SHA, Jul-Mar (Cumulative 3Q) Ordinary Profit Decreases by 15%, Jan-Mar Ordinary Profit Decreases by 16%